Should I buy or sell Thorne HealthTech stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" THRN shares. View THRN analyst ratings or view top-rated stocks .

What is Thorne HealthTech's stock price target for 2024?

2 brokers have issued 12-month target prices for Thorne HealthTech's stock. Their THRN share price targets range from $7.00 to $10.20. On average, they expect the company's share price to reach $8.60 in the next year. This suggests that the stock has a possible downside of 15.6%. View analysts price targets for THRN or view top-rated stocks among Wall Street analysts .

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) posted its earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?

(THRN) raised $98 million in an initial public offering on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

Who are Thorne HealthTech's major shareholders?

Thorne HealthTech's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Gabelli Funds LLC (1.55%), Beryl Capital Management LLC (1.16%), Alpine Associates Management Inc. (1.13%), Qube Research & Technologies Ltd (0.60%), New York Life Investment Management LLC (0.30%) and GABELLI & Co INVESTMENT ADVISERS INC. (0.26%). View institutional ownership trends .

Thorne HealthTech Stock Price, News & Analysis (NASDAQ:THRN)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.19
▼
$10.19
50-Day Range: $10.13
▼
$10.20
52-Week Range: $3.41
▼
$10.20

Volume: N/A
Average Volume: 110,986 shs
Market Capitalization: $549.44 million

P/E Ratio: 26.82
Dividend Yield: N/A
Price Target: $8.60

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Short Interest Social Media

Thorne HealthTech MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 15.6% Downside
$8.60 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 206.90%
From $0.29 to $0.89 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.46 out of 5 stars

1.3

Analyst's Opinion

Consensus Rating
Thorne HealthTech has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.60, Thorne HealthTech has a forecasted downside of 15.6% from its current price of $10.19.
Amount of Analyst Coverage
Thorne HealthTech has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for THRN.

0.0

Dividend Strength

Dividend Yield
Thorne HealthTech does not currently pay a dividend.
Dividend Growth
Thorne HealthTech does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for THRN.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Thorne HealthTech this week, compared to 1 article on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Thorne HealthTech insiders have not sold or bought any company stock.
Percentage Held by Insiders
75.00% of the stock of Thorne HealthTech is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 9.48% of the stock of Thorne HealthTech is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Thorne HealthTech are expected to grow by 206.90% in the coming year, from $0.29 to $0.89 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Thorne HealthTech is 26.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 109.66.
Price to Earnings Ratio vs. Sector
The P/E ratio of Thorne HealthTech is 26.82, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 295.10.
Price to Book Value per Share Ratio
Thorne HealthTech has a P/B Ratio of 3.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Thorne HealthTech Stock (NASDAQ:THRN)

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

THRN Stock News Headlines

December 8, 2023 | bbc.com

Bella Thorne, OnlyFans and the battle over monetising content

November 17, 2023 | health.usnews.com

Dr. Doris K. Thorne

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

October 16, 2023 | finance.yahoo.com

L Catterton Completes Acquisition of Thorne HealthTech, Inc.

October 13, 2023 | finance.yahoo.com

L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer

October 11, 2023 | msn.com

Evercore ISI Group Downgrades Thorne Healthtech (THRN)

September 20, 2023 | markets.businessinsider.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Thorne HealthTech, Inc. (THRN)

September 19, 2023 | finance.yahoo.com

Should You Be Adding Thorne HealthTech (NASDAQ:THRN) To Your Watchlist Today?

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

September 7, 2023 | bloomberg.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN

August 30, 2023 | msn.com

TD Cowen Downgrades Thorne Healthtech (THRN)

August 30, 2023 | benzinga.com

THORNE HEALTHTECH INVESTOR ALERT by the Former...

August 29, 2023 | jp.reuters.com

Thorne HealthTech Inc

August 28, 2023 | benzinga.com

Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton

August 28, 2023 | msn.com

Thorne HealthTech Goes Private In $680M Cash Deal With L Catterton; Stock Soars

August 28, 2023 | finance.yahoo.com

Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash

August 23, 2023 | msn.com

Thorne HealthTech trades higher, extending month-long gains

August 23, 2023 | finance.yahoo.com

Investing in Thorne HealthTech (NASDAQ:THRN) a year ago would have delivered you a 46% gain

August 22, 2023 | msn.com

TWOU, OTLY and LWAY among mid-day movers

August 12, 2023 | seekingalpha.com

Thorne HealthTech, Inc. 2023 Q2 - Results - Earnings Call Presentation

August 11, 2023 | msn.com

Portfolio Change: Two Stocks To Sell, August 11

August 9, 2023 | seekingalpha.com

Thorne HealthTech Non-GAAP EPS of $0.15, revenue of $72.7M

August 9, 2023 | msn.com

Update: THRN and FREE, August 9

August 9, 2023 | finanznachrichten.de

Thorne HealthTech, Inc.: Thorne HealthTech Reports Second Quarter 2023 Results

August 8, 2023 | finance.yahoo.com

Thorne HealthTech Reports Second Quarter 2023 Results

August 8, 2023 | benzinga.com

Thorne HealthTech's Earnings Outlook

August 1, 2023 | finance.yahoo.com

Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8

See More Headlines

Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 12/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Packaged Foods
Sub-Industry: N/A
Sector: Consumer Defensive
Current Symbol: NASDAQ:THRN
CUSIP: N/A
CIK: 1844280
Web: www.thorne.com
Phone: 929-251-6321
Fax: N/A
Employees: 544
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $8.60
High Stock Price Target: $10.20
Low Stock Price Target: $7.00
Potential Upside/Downside: -15.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.38
Trailing P/E Ratio: 26.82
Forward P/E Ratio: 35.14
P/E Growth: N/A
Net Income: $15.67 million
Net Margins: 7.84%
Pretax Margin: 5.59%
Return on Equity: 9.03%
Return on Assets: 5.57%

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 2.41
Quick Ratio: 1.13

Sales & Book Value

Annual Sales: $228.73 million
Price / Sales: 2.40
Cash Flow: $0.26 per share
Price / Cash Flow: 39.41
Book Value: $2.78 per share
Price / Book: 3.67

Miscellaneous

Outstanding Shares: 53,920,000
Free Float: 13,480,000
Market Cap: $549.44 million
Optionable: Not Optionable
Beta: 0.82

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Paul F. Jacobson (Age 68)
Co-Founder, CEO & Chairman
Comp: $965k
Mr. William C. McCamy (Age 53)
Pres
Comp: $478.95k
Ms. Saloni S. Varma (Age 44)
CFO & Director
Comp: $75k
Mr. Thomas P. McKenna (Age 63)
COO & Director
Comp: $805.95k
Mr. Scott R. Hurth (Age 43)
Chief Technology Officer
Dr. Nathan D. Price Ph.D. (Age 47)
Chief Scientific Officer & CEO of Onegevity
Mr. Thomas Wilson
VP & Head of Investor Relations
Mr. Kim R. Pearson (Age 71)
Gen. Counsel
Ms. Michelle L. Crow (Age 33)
Chief Marketing Officer
Mr. Rob Monteleone
Sr. VP of Professional Sales

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

THRN Stock Analysis - Frequently Asked Questions

Should I buy or sell Thorne HealthTech stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" THRN shares.
View THRN analyst ratings or view top-rated stocks.
What is Thorne HealthTech's stock price target for 2024?: 2 brokers have issued 12-month target prices for Thorne HealthTech's stock. Their THRN share price targets range from $7.00 to $10.20. On average, they expect the company's share price to reach $8.60 in the next year. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for THRN or view top-rated stocks among Wall Street analysts.
How were Thorne HealthTech's earnings last quarter?: Thorne HealthTech, Inc. (NASDAQ:THRN) posted its earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?: (THRN) raised $98 million in an initial public offering on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.
Who are Thorne HealthTech's major shareholders?: Thorne HealthTech's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Gabelli Funds LLC (1.55%), Beryl Capital Management LLC (1.16%), Alpine Associates Management Inc. (1.13%), Qube Research & Technologies Ltd (0.60%), New York Life Investment Management LLC (0.30%) and GABELLI & Co INVESTMENT ADVISERS INC. (0.26%).
View institutional ownership trends.

This page (NASDAQ:THRN) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Thorne HealthTech Stock Price, News & Analysis (NASDAQ:THRN)

Thorne HealthTech MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Company Ownership

Earnings and Valuation

About Thorne HealthTech Stock (NASDAQ:THRN)

THRN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

THRN Stock Analysis - Frequently Asked Questions

Overall MarketRank^™